- active not recruitingPHASE2
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
This study is looking at a new drug called adagrasib for people with a specific type of advanced lung cancer. It focuses on patients who are older (70+) or have poorer health, to see how well the drug works in shrinking their cancer.
Belgium · France · Ireland - not yet recruitingNA
Exercise in Patients With Advanced Non-small Cell Lung Cancer
This study looks at how exercise, like walking or strength training, might help people in the UK with advanced lung cancer. It aims to see if exercise can improve tiredness, strength, and overall well-being alongside their usual cancer treatment.
Germany